These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18955814)

  • 41. Prenostodione, a novel UV-absorbing metabolite from a natural bloom of the cyanobacterium Nostoc species.
    Ploutno A; Carmeli S
    J Nat Prod; 2001 Apr; 64(4):544-5. PubMed ID: 11325247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors.
    McGlinchey RP; Nett M; Eustáquio AS; Asolkar RN; Fenical W; Moore BS
    J Am Chem Soc; 2008 Jun; 130(25):7822-3. PubMed ID: 18512922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decoding cyclase-dependent assembly of hapalindole and fischerindole alkaloids.
    Li S; Lowell AN; Newmister SA; Yu F; Williams RM; Sherman DH
    Nat Chem Biol; 2017 May; 13(5):467-469. PubMed ID: 28288107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Knowledge on Microviridin from Cyanobacteria.
    do Amaral SC; Monteiro PR; Neto JDSP; Serra GM; Gonçalves EC; Xavier LP; Santos AV
    Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33406599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent developments in therapeutic applications of Cyanobacteria.
    Raja R; Hemaiswarya S; Ganesan V; Carvalho IS
    Crit Rev Microbiol; 2016 May; 42(3):394-405. PubMed ID: 25629310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of a cyclic carbonate, a gamma-butyrolactone, and a new indole derivative from the marine cyanobacterium Lyngbya majuscula.
    Todd JS; Gerwick WH
    J Nat Prod; 1995 Apr; 58(4):586-9. PubMed ID: 7623035
    [No Abstract]   [Full Text] [Related]  

  • 47. Laucysteinamide A, a Hybrid PKS/NRPS Metabolite from a Saipan Cyanobacterium, cf. Caldora penicillata.
    Zhang C; Naman CB; Engene N; Gerwick WH
    Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28420100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An unstructured proteasome inhibitor comes into focus.
    Nemec AA; Tomko RJ
    J Biol Chem; 2023 Sep; 299(9):105145. PubMed ID: 37562568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anabaenopeptins: What We Know So Far.
    Monteiro PR; do Amaral SC; Siqueira AS; Xavier LP; Santos AV
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbial and fungal protease inhibitors--current and potential applications.
    Sabotič J; Kos J
    Appl Microbiol Biotechnol; 2012 Feb; 93(4):1351-75. PubMed ID: 22218770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In search of the optimal proteosome inhibitor. How, when and for whom?
    Engelhardt M; Bringhen S; Moreau P; Wäsch R; Waldschmidt J
    Haematologica; 2021 Oct; 106(10):2539-2541. PubMed ID: 33910336
    [No Abstract]   [Full Text] [Related]  

  • 52. Polyphasic evaluation and cytotoxic investigation of isolated cyanobacteria with an emphasis on potent activities of a
    Ngo TT; Nguyen BT; Duong TA; Nguyen TT; Nguyen TL; Kieu KT; Do MT; Nguyen SV; Thang ND; Pham HTL
    Front Microbiol; 2022; 13():1025755. PubMed ID: 36386649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nostocyclopeptides as New Inhibitors of 20S Proteasome.
    Fidor A; Cekała K; Wieczerzak E; Cegłowska M; Kasprzykowski F; Edwards C; Mazur-Marzec H
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Report on Finding a New Peptide Aldehyde from Cyanobacterium
    Nowruzi B; Wahlsten M; Jokela J
    Iran J Biotechnol; 2019 Apr; 17(2):e1853. PubMed ID: 31457050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Products from Cyanobacteria: Focus on Beneficial Activities.
    Demay J; Bernard C; Reinhardt A; Marie B
    Mar Drugs; 2019 May; 17(6):. PubMed ID: 31151260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of three cell-based drug screening platforms for HSV-1 infection.
    D'Aiuto L; Williamson K; Dimitrion P; McNulty J; Brown CE; Dokuburra CB; Nielsen AJ; Lin WJ; Piazza P; Schurdak ME; Wood J; Yolken RH; Kinchington PR; Bloom DC; Nimgaonkar VL
    Antiviral Res; 2017 Jun; 142():136-140. PubMed ID: 28342892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and structure determination of a proteasome inhibitory metabolite from a culture of Scytonema hofmanni.
    Shim SH; Chlipala G; Orjala J
    J Microbiol Biotechnol; 2008 Oct; 18(10):1655-8. PubMed ID: 18955814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteasome structure, function, and lessons learned from beta-lactone inhibitors.
    Groll M; Potts BC
    Curr Top Med Chem; 2011 Dec; 11(23):2850-78. PubMed ID: 21824111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
    Tsukamoto S; Yokosawa H
    Planta Med; 2010 Aug; 76(11):1064-74. PubMed ID: 20186654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug discovery and assay development in the ubiquitin-proteasome system.
    Berkers CR; Ovaa H
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):14-20. PubMed ID: 20074028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.